RI Research Instruments GmbH Receives DESY Contract for 120 RF Cavities
May 07 2013 - 6:24AM
Business Wire
RI Research Instruments GmbH, a majority-owned subsidiary of
Bruker Energy & Supercon Technologies, Inc. (BEST), today
announced the award of an option valued at approximately $7.3
million, for an additional 120 superconducting radio-frequency (rf)
cavities, on top of its on-going 300-cavity contract for the
European XFEL, a new international research facility near Hamburg,
Germany. DESY (Deutsches Elektronen-Synchrotron) is the majority
shareholder of the European XFEL, and in charge of building and
operating the accelerator facility.
Since the initial DESY contract award in September 2010, RI has
built up sophisticated infrastructure such as class ISO4 clean
rooms with high pressure ultra-pure water rinsing stations,
annealing furnaces and chemical plants, all of which are needed to
treat the XFEL superconducting cavities for achieving the goal of
world record accelerating gradients and quality factors.
The proper functioning of this infrastructure was validated by
“reference cavities,” which were first treated in existing and
qualified infrastructure at DESY, followed by a cold rf test at the
research center. The treatment was then repeated using RI
infrastructure and personnel. With the consecutive successful cold
rf test of three RI cavities, all reaching accelerating gradients
above 30 MV/m at quality factors above 1E10, the qualification
phase for the RI infrastructure officially concluded in March 2013.
The start of series cavity shipments under the original 24.9
million Euro contract from DESY is expected to begin in the second
quarter of 2013.
After this qualification achievement, DESY exercised its option
for ordering an additional 120 superconducting 9-cell cavities from
RI. With these 120 additional cavities, RI is now contracted to
deliver a total of 420 cavities for the European XFEL project, out
of which 400 will be used in the accelerator while 20 are either
reference cavities, or for quality assurance followed by dedicated
high accelerating gradient studies. RI is now proceeding with full
series production of the XFEL cavities, with the goal of delivering
at a rate of four cavities per week through early 2015.
Dr. Michael Peiniger, Managing Director of RI Research
Instruments, explained: “With this successful qualification,
industry is now able to put into series production the very complex
superconducting cavity preparation processes that were developed by
the world’s leading research labs to enable accelerating gradients
greater than 30 MV/m. RI is pleased to be a reliable industrial
partner for the European XFEL project, and looks forward to working
on large next-generation projects such as the European Spallation
Source and the future International Linear Collider.”
About RI Research Instruments and Bruker Energy &
Supercon Technologies, Inc.:
RI Research Instruments GmbH (RI) is a world leader in the
development and manufacturing of normal and superconducting rf
cavities and systems, linear accelerators, as well as special
products for physics and energy research, scientific, medical and
industrial applications. RI products also include high-performance
electron and ion sources, particle beamlines and diagnostics,
research reactor subunits, as well as vacuum and cryogenic systems.
BEST has operations in the US, the UK and Germany, and is a
wholly-owned subsidiary of Bruker Corporation (NASDAQ: BRKR).
For more information, please visit: www.research-instruments.de
or www.bruker-est.com
Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20130507005978/en/
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024